http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040007477-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040007477-A |
| titleOfInvention | Remedies for vesical stimulation in association with prostatauxe |
| abstract | The present invention provides a therapeutic agent for bladder hypersensitivity due to benign prostatic hyperplasia, which contains, as an active ingredient, a tricyclic compound represented by formula (I) or a pharmaceutically acceptable salt thereof:n n n [Formula I]n n n n n n n n [Wherein, R 1 represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkoxy or halogen;n n n X 1 -X 2 -X 3 is CR 5 = CR 6 -CR 7 = CR 8 , N (O) m = CR 6 -CR 7 = CR 8 , CR 5 = CR 6 -N (O) m = CR 8 , CR 5 = CR 6 -CR 7 = N (O) m , CR 5 = CR 6 -O, CR 5 = CR 6 -S, O-CR 7 = CR 8 , S-CR 7 = CR 8 or O- CR 7 = N;n n n Y is -CH 2 S-, -CH 2 SO-, -CH 2 SO 2- , -CH 2 O-, -CH = CH-,-(CH 2 ) p- , -SCH 2- , -SOCH 2- , -SO 2 CH 2 -or -OCH 2- ;n n n R 2 is a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkenyl, substituted or unsubstituted lower alkoxy, amino, mono (substituted or unsubstituted lower alkyl) -substituted amino, di (substituted or unsubstituted lower) Alkyl) -substituted amino, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted aralkylamino, substituted or unsubstituted arylamino, or substituted or unsubstituted heteroalicyclic group. |
| priorityDate | 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.